Discover open access scientific publications

Search, annotate, share and cite publications

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

Journal of Thoracic Oncology

Medicine

English

P1.01-105 Lung Cancer Patients With Concurrent EGFR and MET Mutations: A Retrospective Analysis of 29 Cases

Journal of Thoracic Oncology

English

P3.03-02 Single-Cell RNA-Seq in Human Lung Cancer

Journal of Thoracic Oncology

English

P1.11-11 Comparing Lung Cancer Diagnosed by Low Dose CT (LDCT), Incidental Lung Nodule Program (ILNP), and Non-Program-Based Detection

Journal of Thoracic Oncology

English

P1.16-37 Clinicopathological Characteristics and Prognostic Factors of Operable Non-Small Cell Lung Cancer Patients With the Diabetes Mellitus

Journal of Thoracic Oncology

English

P3.01-80 Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients With NSCLC Harboring EGFR Mutations.

Journal of Thoracic Oncology

English

P2.01-52 Identification of Leptomeningeal Metastasis-Specific Exosomal miRNA Signatures in Cerebrospinal Fluids of NSCLC Patients

Journal of Thoracic Oncology

English

P2.01-07 Safety and Efficacy of LATTICE Radiotherapy in Voluminous Non-Small Cell Lung Cancer: A Retrospective Study of 10 Patients Over 7 Year Period

Journal of Thoracic Oncology

English

P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

Corrigendum

American Journal of Sports Medicine

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

OA08.01 Long-Term Efficacy and Safety of Nivolumab in Second- Or Third-Line Japanese Malignant Pleural Mesothelioma Patients (Phase II: MERIT Study)

P1.01-105 Lung Cancer Patients With Concurrent EGFR and MET Mutations: A Retrospective Analysis of 29 Cases

P3.03-02 Single-Cell RNA-Seq in Human Lung Cancer

P1.11-11 Comparing Lung Cancer Diagnosed by Low Dose CT (LDCT), Incidental Lung Nodule Program (ILNP), and Non-Program-Based Detection

P1.16-37 Clinicopathological Characteristics and Prognostic Factors of Operable Non-Small Cell Lung Cancer Patients With the Diabetes Mellitus

P3.01-80 Retrospective Analysis of the Impact of EGFR T790M Mutation Detection by Re-Biopsy in Patients With NSCLC Harboring EGFR Mutations.

P2.01-52 Identification of Leptomeningeal Metastasis-Specific Exosomal miRNA Signatures in Cerebrospinal Fluids of NSCLC Patients

P2.01-07 Safety and Efficacy of LATTICE Radiotherapy in Voluminous Non-Small Cell Lung Cancer: A Retrospective Study of 10 Patients Over 7 Year Period

P2.01-113 Prognostic Roles of Neoadjuvant and Adjuvant Chemotherapy for Treating Patients With Operable Stage III-N2 Non-Small Cell Lung Cancer (NSCLC)

Corrigendum